OQROGet OQRO Pro
Politician trade (House)

Johnson & Johnson (JNJ)Rep. George Whitesides (CA27) disclosed a sale $100K–$250K

Rep. George Whitesides (CA27) disclosed a sale of Johnson & Johnson in the $100K–$250K range.

$100,001–$250,000
Reported range · official band, not an exact amount
30 days
Disclosure lag
Traded
Mar 24, 2025
Disclosed
Apr 23, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 7, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Jan 8, 2025Congress · 1 personMembers of Congress: 4 purchases
  3. Jan 16, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Jan 21, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Jan 24, 2025Congress · 2 peopleMembers of Congress: 1 purchase, 1 sale
  6. Feb 7, 2025InsiderCFO sold ~$2M of JNJ shares in the open market
  7. Feb 18, 2025InsiderChair sold ~$63K of JNJ shares in the open market
  8. Feb 24, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  9. Feb 25, 2025InsiderOfficer sold ~$1.16M of JNJ shares in the open market
  10. Mar 3, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  11. Mar 4, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  12. Mar 5, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  13. Mar 7, 2025FDARecall: PDS¿PLUS¿VIO¿30IN(75CM)¿USP6-0(M0.7)¿D/A¿C-1¿MP
  14. Mar 7, 2025FDARecall: PROLENE BLU 18IN(45CM) USP6-0(M0.7) S/A P-1 PRM
  15. Mar 7, 2025FDARecall: ETHIBOND EXCEL GRN 36IN(90CM) USP2-0(M3) D/A MH
  16. Mar 7, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  17. Mar 20, 2025FDAFDA drug approval: Tremfya
  18. Mar 21, 2025FDAFDA drug approval: Prezcobix
  19. Mar 24, 2025 · this disclosureCongressDisclosed sale of JNJ — reported range $100,001 - $250,000

What came next

  1. Mar 28, 2025FDAFDA device clearance: Synthes Graphic Case & Tray System
  2. Mar 31, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  3. Apr 1, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  4. Apr 8, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  5. Apr 9, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  6. Apr 10, 2025FDAFDA drug approval: Darzalex
  7. Apr 21, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  8. Apr 22, 2025FDARecall: Endopath Echelon Vascular White Reload for Advanced Placement Tip (35mm, 4 row); Product code VASECR35
  9. Apr 24, 2025FDAFDA device clearance: MENTOR™ PliaForm™ Breast Tissue Expander w/ Suture Tabs
  10. Apr 29, 2025FDAFDA drug approval: Imaavy
  11. Apr 29, 2025Congress · 1 personMembers of Congress: 2 sales
  12. May 2, 2025FDAFDA device clearance: Shockwave CS Guide Catheter
  13. May 5, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  14. May 12, 2025CongressDisclosed sale of JNJ — reported range $50,001 - $100,000
  15. May 14, 2025FDAFDA device clearance: ETHICON 4000 60mm Compact Stapler (EC3D60C); ETHICON 4000 60mm Standard Stapler (EC3D60S); ETHICON 4000 60mm Long Stapler (EC3D60L); ETHICON 3D 60mm White Relo…
  16. May 23, 2025FDAFDA device clearance: RECLAIM Monobloc Revision Femoral Stem
  17. May 30, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  18. Jun 10, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  19. Jun 12, 2025FDARecall: ACUVUE¿ OASYS MAX 1-Day MULTIFOCAL
  20. Jun 12, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. George Whitesides (CA27)

The full history of Rep. George Whitesides (CA27) is on the profile page.

How this filing works

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data